Mangold Fondkommission AB has from March 20, 2009 terminated its obligation as liquidity provider for Diamyd Medical AB TO 2B. For further information concerning this exchange notice please call Anna-Karin Teir or Emelie Jarnesten at + 46 8 405 60 00. OMX Nordic Exchange Stockholm
Equities:Termination of liquidity provider, Diamyd Medical AB TO 2B (51/09)
| Source: Nasdaq Stockholm AB